Smart Adherence Potential customers include pharmaceutical firms and device manufacturers seeking connected dosing solutions for injectable medicines; target partnerships with Haselmeier and other pen-injector brands to expand the Gocap smart cap ecosystem.

Clinical Partnerships Leverage past collaborations and board connections to pursue pilot programs with diabetes and neurodegenerative disease initiatives that require adherence monitoring, leveraging the Gocap data to improve outcomes and payer value propositions.

Data Enablement Position Gocap as a data-driven differentiator by offering integrated drug-delivery analytics to pharma and device OEMs, highlighting potential to reduce non-adherence and support remote patient monitoring initiatives.

Early Stage Advantage As a small team with lean operations and a Series A history, pursue strategic partnerships with larger digital health and medical device players for co-development, co-marketing, or OEM integration to accelerate go-to-market.

Global Market Fit Target mid-to-large medical device and diabetes/insulin solution providers with comparable revenue ranges to peers; emphasize scalable software, cloud capabilities, and compatibility with common tech stack to ease integration.